Giovanna De Santis
Avellino, 83100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience.
Journal: Hematology reports
Published: December 24, 2023
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients.
Journal: Cancer reports (Hoboken, N.J.)
Published: October 28, 2023
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma.
Journal: Annals of hematology
Published: June 19, 2017
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.
Journal: Mediterranean journal of hematology and infectious diseases
Published: June 25, 2016
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.
Journal: Mycoses
Published: September 04, 2015
Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.
Journal: Mediterranean journal of hematology and infectious diseases
Published: September 01, 2014
Extensive toxic epidermal necrolysis following brentuximab vedotin administration.
Journal: Annals of hematology
Published: June 18, 2014
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Journal: Haematologica
Published: June 08, 2014
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
Journal: Annals of hematology
Published: March 30, 2014
Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.
Journal: Annals of hematology
Published: November 11, 2013
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy.
Journal: Leukemia research and treatment
Published: January 16, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026